Skip to main content
Martin Tolar, MD, Neurology, New Haven, CT

Martin Tolar MD


Physician

Join to View Full Profile
  • 800 Howard Ave"# YPB-3"New Haven, CT 06519

  • Phone+1 203-785-4085

Are you Dr. Tolar?

Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.

  • Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Summary

  • Dr. Martin Tolar, MD is a neurologist in New Haven, Connecticut. He is currently licensed to practice medicine in Connecticut and Massachusetts.

Education & Training

  • Boston University Medical Center
    Boston University Medical CenterResidency, Neurology, 1998 - 2001
  • Charles University in Prague Faculty of Medicine
    Charles University in Prague Faculty of MedicineClass of 1991

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 1999 - 2026
  • CT State Medical License
    CT State Medical License 2002 - 2007

Publications & Presentations

PubMed

Press Mentions

  • Alzheon to Present Industry-Leading Biomarker, Brain Preservation, and Clinical Effects with Oral ALZ-801 (Valiltramiprosate) at 15th Annual Clinical Trials in Alzheimer’s Disease Conference
    Alzheon to Present Industry-Leading Biomarker, Brain Preservation, and Clinical Effects with Oral ALZ-801 (Valiltramiprosate) at 15th Annual Clinical Trials in Alzheimer’s Disease ConferenceNovember 22nd, 2022
  • Alzheon Reports Industry-Leading Biomarker, Brain Preservation and Clinical Effects Following 12 Months of Treatment in Phase 2 Trial of Oral ALZ-801 (Valiltramiprosate) in Patients with Early Alzheimer’s Disease
    Alzheon Reports Industry-Leading Biomarker, Brain Preservation and Clinical Effects Following 12 Months of Treatment in Phase 2 Trial of Oral ALZ-801 (Valiltramiprosate) in Patients with Early Alzheimer’s DiseaseSeptember 20th, 2022
  • Alzheon Appoints Glenn Pauly as Head of Commercial
    Alzheon Appoints Glenn Pauly as Head of CommercialSeptember 20th, 2022
  • Join now to see all